PacBio Reports 54 Percent Increase in Q4 Revenues | GenomeWeb

NEW YORK (GenomeWeb News) – Pacific Biosciences reported after the close of the market Tuesday that its fourth quarter 2013 revenues grew 54 percent year over year and 23 percent sequentially.

The Menlo Park, Calif.-based single-molecule sequencing technologies firm reported Q4 revenues of $9.1 million, compared to just $5.9 million in Q4 2012 and up from $7.4 million in Q3 2013. It matched the consensus Wall Street estimate.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: personal genome approach to RNA-seq read alignment, hematopoietic Systems Biology Repository, and more.

A man is using DNA evidence to argue that he is the rightful heir to the baronetcy of Stichill, the Guardian reports.

As part of an effort to get a diverse group of people to donate their DNA for research, some blood donors in the San Diego area will get their genomes sequenced, according to KPBS.

The comment period on the Department of Health and Human Services' proposal to alter the Common Rule has been extended.